麗新製衣(00191.HK)收購橫琴國家地理探險家中心剩餘30%股權
麗新製衣(00191.HK)公布,旗下麗新發展(00488.HK)及麗豐(01125.HK)分別持股20%及80%的業佳,向中國信達(01359.HK)旗下中國信達(香港),收購榮立的30%股權及股東貸款,代價合共近926.9萬美元。
收購完成後,業佳將全資擁有榮立。榮立旗下GSL集團目前主要營運事橫琴國家地理探險家中心,該中心為親子學習體驗中心,設有18項個別特色體驗。
麗新製衣預期,GSL集團業務將會受益於位於橫琴的粵澳深度合作區持續發展,以及澳門與橫琴的進一步融合。(gc/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.